ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 259 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $649,000 | -6.6% | 6,984 | -40.2% | 0.00% | -50.0% |
| Q3 2021 | $695,000 | -11.8% | 11,680 | +1.1% | 0.00% | 0.0% |
| Q2 2021 | $788,000 | -2.5% | 11,556 | -0.9% | 0.00% | 0.0% |
| Q1 2021 | $808,000 | -12.1% | 11,656 | -2.6% | 0.00% | -33.3% |
| Q4 2020 | $919,000 | +15.0% | 11,971 | +12.0% | 0.00% | 0.0% |
| Q3 2020 | $799,000 | +37.8% | 10,688 | +15.9% | 0.00% | +50.0% |
| Q2 2020 | $580,000 | +83.0% | 9,218 | +21.8% | 0.00% | +100.0% |
| Q1 2020 | $317,000 | +18.3% | 7,568 | +28.1% | 0.00% | 0.0% |
| Q4 2019 | $268,000 | -0.4% | 5,908 | +0.2% | 0.00% | 0.0% |
| Q3 2019 | $269,000 | -31.4% | 5,897 | -11.9% | 0.00% | -50.0% |
| Q2 2019 | $392,000 | +41.5% | 6,693 | +8.3% | 0.00% | +100.0% |
| Q1 2019 | $277,000 | +22.0% | 6,182 | +5.6% | 0.00% | 0.0% |
| Q4 2018 | $227,000 | -15.6% | 5,852 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $269,000 | +15.0% | 5,852 | +9.3% | 0.00% | 0.0% |
| Q2 2018 | $234,000 | +4.0% | 5,356 | -6.2% | 0.00% | 0.0% |
| Q1 2018 | $225,000 | – | 5,707 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 4,190,000 | $321,918,000 | 5.54% |
| Prosight Management, LP | 145,700 | $11,194,000 | 5.17% |
| Integral Health Asset Management, LLC | 200,000 | $15,366,000 | 4.57% |
| Copernicus Capital Management, LLC | 3,740 | $287,000 | 4.47% |
| GREAT POINT PARTNERS LLC | 345,120 | $26,516,000 | 4.31% |
| Asymmetry Capital Management, L.P. | 101,245 | $7,779,000 | 3.55% |
| First Light Asset Management, LLC | 321,967 | $24,737,000 | 1.83% |
| DAFNA Capital Management LLC | 76,815 | $5,902,000 | 1.76% |
| SECTORAL ASSET MANAGEMENT INC | 320,059 | $24,590,000 | 1.73% |
| Nicholas Investment Partners, LP | 276,633 | $21,254,000 | 1.64% |